JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Strona główna・Stock List・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Closed

1.14 4.59

Buy Sell

Overview

Share price change

24h

Current

Min

1.1400000000000001

Max

1.15

Key metrics
By Trading Economics
Income	17M -26M
Employees	171
EBITDA	19M -23M

Recommendations
By TipRanks
Recommendations	Sell
12 Months Forecast	+250.88% upside

Dividends
By Dow Jones
Next Earnings	26 lut 2026

Market Stats
By TradingEconomics
Market Cap	-29M 73M
Previous open	-3.45
Previous close	1.14

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

1.43 / 1.6 Support & Resistance

Pliant Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 lut 2026, 23:57 UTC

Market Talk

Uranium Outlook Heats Up on Rising Demand, Uncertain Supply -- Market Talk

8 lut 2026, 23:47 UTC

Market Talk

Gold Rises Amid Growing U.S.-Iran Tensions -- Market Talk

8 lut 2026, 23:43 UTC

Market Talk

Nikkei Likely to Rise Sharply After Takaichi's Election Win -- Market Talk

8 lut 2026, 23:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 lut 2026, 23:34 UTC

Market Talk

Landslide Election Victory of Japan's LDP Positive for Risk Assets -- Market Talk

8 lut 2026, 23:26 UTC

Market Talk

Yen Skittish; Nikkei Jumps On LDP Landslide -- Market Talk

8 lut 2026, 22:55 UTC

Earnings

DBS Group 4Q Net S$2.36B Vs. Net S$2.62B >D05.SG

8 lut 2026, 22:55 UTC

Earnings

DBS Group 4Q Net Interest Income S$3.59B Vs. S$3.83B>D05.SG

8 lut 2026, 22:55 UTC

Earnings

DBS Board Proposes 4Q Dividend of 66 Singapore Cents/share>D05.SG

8 lut 2026, 22:55 UTC

Earnings

DBS Group: 2025 Total Dividend at S$3.06/share >D05.SG

8 lut 2026, 22:55 UTC

Earnings

DBS Group 4Q Net Weighed by Higher Tax Expense, Absence of Non-Recurring Gains Recrorded Last Year >D05.SG

8 lut 2026, 22:55 UTC

Earnings

DBS Group 4Q Total Income S$5.33B Vs. S$5.51B>D05.SG

8 lut 2026, 21:43 UTC

Market Talk

FX Intervention Watch Resumes After Japan Election Result -- Market Talk

8 lut 2026, 21:16 UTC

Market Talk

Right Of Australian Politics Reshaped as One Nation Surges -- Market Talk

8 lut 2026, 21:15 UTC

Market Talk

Japan's Election Outcome to Revive Takaichi Trade -- Market Talk

7 lut 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7 lut 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

7 lut 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7 lut 2026, 02:46 UTC

Acquisitions, Mergers, Takeovers

Big Money, High Anxiety -- Barrons.com

6 lut 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 lut 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

6 lut 2026, 21:40 UTC

Acquisitions, Mergers, Takeovers

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

6 lut 2026, 21:22 UTC

Market Talk

Mexico's Inflation Seen Accelerating in January -- Market Talk

6 lut 2026, 21:17 UTC

Earnings

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6 lut 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 lut 2026, 21:14 UTC

Acquisitions, Mergers, Takeovers

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

6 lut 2026, 21:13 UTC

Earnings

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

6 lut 2026, 21:13 UTC

Earnings

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

6 lut 2026, 21:04 UTC

Market Talk

Gold Closes Out Volatile Week on Higher Note -- Market Talk

6 lut 2026, 20:34 UTC

Earnings

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

Peer Comparison

Price change

Pliant Therapeutics Inc Forecast

Price Target

By TipRanks

250.88% upside

12 Months Forecast

Average 4 USD 250.88%

High 4 USD

Low 4 USD

Based on 2 Wall Street analysts offering 12 month price targets forPliant Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Sell

2 ratings

Buy

Hold

Sell

Based on 2 analysts giving stock ratings to Pliant Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

1.43 / 1.6Support & Resistance

Recent bearish events outweigh bullish events.

There is one bearish event.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.